Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
about
Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsetsElevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesisThe E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNAAltered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysisRole of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections.Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis.Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses.Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complexEvidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturitionUse of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVIL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.Basal Autophagy Is Required for Herpes simplex Virus-2 InfectionA critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production.Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusAntiviral immune responses in the genital tract: clues for vaccines.Role of Bacterial Exopolysaccharides as Agents in Counteracting Immune Disorders Induced by Herpes Virus.Pharmacologic and chemical adjuvants in tumor virotherapy.How diverse--CD4 effector T cells and their functions.IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenicRecognition of herpes simplex viruses: toll-like receptors and beyondRegulatory T cells: immune suppression and beyond.Oncolytic herpes simplex virus interactions with the host immune system.Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes.Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica.Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit.Decreased susceptibility of mice to infection with Listeria monocytogenes in the absence of interleukin-18.Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.Expression of IL-18 by Mycobacterium avium-infected human monocytes; association with M. avium virulence
P2860
Q27002464-15AA2EDA-B4B0-4202-A019-E62328571E2CQ27489815-32073438-DB14-4868-BC97-1346557D710AQ28507251-52C573EE-021C-4592-A910-8457D4550D69Q33675567-DC7C51E5-1D20-48A0-B625-5747D22A351CQ34002652-7A12BB1A-F6B0-49C0-B323-6E6351B77C99Q34335296-8377ACCC-FE30-41DB-BB1D-A60053400FBCQ34350113-E0F3B189-CA38-4757-8F67-9C536FB5091AQ34353054-7EB7D154-9145-4E7B-BDFE-A8B1F81D5459Q34582210-BE1C9087-56BB-4E1C-BC16-4000ED9A9853Q34979025-59740B40-92A9-470D-81C0-15C9CC3AB858Q35186914-B8D2326A-922F-4C88-AE9C-A941C08FFFEEQ35591421-BBC7C5A8-8071-4D2F-B0D6-B9D0A8585828Q35655365-24F2CD41-0D99-45BC-8020-CD3FD5AC2983Q35926147-FDAEFDBB-7221-4DD4-A442-2975A22BABF8Q36369443-CD1CE701-28C1-4E5E-A33A-B80739E827D7Q36464830-E8E9269A-449F-4A08-B58A-847B8DA8A82DQ36879345-4EDE9506-E8B6-4B7D-8D99-E726768ED531Q36918159-05630A51-7782-4552-B8A0-D39DAECAD691Q37255937-4E2BE4AD-962B-41E2-A520-DE532248883CQ37492540-D56714EC-28E8-466C-B11C-3FD8F58BF198Q37502276-028131F1-3C1A-4949-921C-A9CDF2E71E0DQ37617613-C9161DB0-B6E5-464F-B5AB-5A54E9C326B2Q37619828-55302440-89CE-4181-9993-D98B98CCC7E9Q37728843-1514973E-F56E-443E-A8E3-C23FAB2325D5Q38920459-523FA9A0-2DAD-45EE-AE11-8A90603E063CQ39191187-2593F1AC-BD95-4EC1-BEEE-C359C74FD678Q39514613-D5A78DE7-0C9F-4991-B6FD-05FDF609C567Q41836613-3459AA74-640F-4ABD-A756-B658FC568F48Q42406506-F95AFEAD-F9A5-4300-877F-EEDC7B4636F9Q45533775-AA4F729E-8317-45F7-86A9-E3F3DF70F085Q58329486-016FA6C5-28B9-4B52-AE6D-A25BA5B3EB2A
P2860
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
@ast
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
@en
type
label
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
@ast
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
@en
prefLabel
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
@ast
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.
@en
P2093
P2860
P1433
P1476
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection
@en
P2093
P2860
P304
P577
1999-03-01T00:00:00Z